It’s the end of an era as the world’s first commercial biologics plant—once home to a secretive project dubbed “Orange Marmalade”—turns out the lights. After years of planning, Genentech is winding ...

Batavia Biosciences is entering the commercial manufacturing game. The CDMO said today that it has finalized plans for a new 12,000-square-meter building to be constructed at the Bioscience Park in ...

Check out our list to see what Nidec Power, Lilly, Woodward and other companies have announced in recent weeks.

Matica Bio announced a strategic commercial manufacturing agreement with a biotech company based in the United States. This partnership marks a significant milestone as Matica Bio initiates GMP ...

Lifecore Biomedical, Inc. announced a new 10-year commercial manufacturing and supply agreement with one of its existing customers to support the development of a novel ophthalmic therapeutic. This ...

The success of the mRNA vaccines for COVID-19 led to explosive growth in lipid nanoparticle (LNP)-mediated drug delivery for RNA vaccines and therapeutics. As these projects scale into clinical trials ...

Curran Simpson, President and CEO, highlighted strong late-stage clinical progress and the company's positioning for multiple gene therapy launches, stating the business is “in-store for an exciting ...

BOCA RATON, Fla., Sept. 15, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (“INmune” or “the Company”), a clinical-stage inflammation and immunology company focused on developing treatments ...